KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Common Equity: 2009-2025

Historic Common Equity for Quest Diagnostics (DGX) over the last 17 years, with Sep 2025 value amounting to $7.3 billion.

  • Quest Diagnostics' Common Equity rose 6.64% to $7.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.3 billion, marking a year-over-year increase of 6.64%. This contributed to the annual value of $6.8 billion for FY2024, which is 7.43% up from last year.
  • Quest Diagnostics' Common Equity amounted to $7.3 billion in Q3 2025, which was up 0.41% from $7.3 billion recorded in Q2 2025.
  • Over the past 5 years, Quest Diagnostics' Common Equity peaked at $7.3 billion during Q3 2025, and registered a low of $5.9 billion during Q4 2022.
  • For the 3-year period, Quest Diagnostics' Common Equity averaged around $6.7 billion, with its median value being $6.7 billion (2024).
  • Per our database at Business Quant, Quest Diagnostics' Common Equity increased by 19.06% in 2021 and then decreased by 8.53% in 2022.
  • Quarterly analysis of 5 years shows Quest Diagnostics' Common Equity stood at $6.5 billion in 2021, then fell by 8.53% to $5.9 billion in 2022, then rose by 6.95% to $6.3 billion in 2023, then climbed by 7.43% to $6.8 billion in 2024, then climbed by 6.64% to $7.3 billion in 2025.
  • Its last three reported values are $7.3 billion in Q3 2025, $7.3 billion for Q2 2025, and $7.0 billion during Q1 2025.